186 related articles for article (PubMed ID: 8543305)
21. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
22. The gender disparity of immunoreactants in lesional skin of lupus erythematosus patients.
Yu M; Li KW; Tan GZ; Luo T; Xu DQ; Wang L
Clin Exp Rheumatol; 2012; 30(1):103-5. PubMed ID: 22260779
[TBL] [Abstract][Full Text] [Related]
23. Mannose binding lectin deposition in skin of lupus erythematosus patients: a case series.
Wallim LR; Nisihara R; Skare T; Mocelin V; Messias-Reason IJ
Hum Immunol; 2014 Jul; 75(7):629-32. PubMed ID: 24798938
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients.
Nabatian AS; Bashir MM; Wysocka M; Sharma M; Werth VP
Arthritis Res Ther; 2012 Jan; 14(1):R1. PubMed ID: 22217359
[TBL] [Abstract][Full Text] [Related]
25. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
Chlebus E; Wolska H; Blaszczyk M; Jablonska S
J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
[TBL] [Abstract][Full Text] [Related]
26. Microvascular alterations and the role of complement in dermatomyositis.
Lahoria R; Selcen D; Engel AG
Brain; 2016 Jul; 139(Pt 7):1891-903. PubMed ID: 27190020
[TBL] [Abstract][Full Text] [Related]
27. The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus.
Nakamura K; Jinnin M; Kudo H; Inoue K; Nakayama W; Honda N; Kajihara I; Masuguchi S; Fukushima S; Ihn H
Br J Dermatol; 2016 May; 174(5):1030-41. PubMed ID: 26713607
[TBL] [Abstract][Full Text] [Related]
28. Activation/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus.
Alahlafi A; Wordsworth P; Wojnarowska F
J Cutan Pathol; 2005 Sep; 32(8):537-40. PubMed ID: 16115051
[TBL] [Abstract][Full Text] [Related]
29. Marked papillary dermal edema--an unreliable discriminator between polymorphous light eruption and lupus erythematosus or dermatomyositis.
Pincus LB; LeBoit PE; Goddard DS; Cho RJ; McCalmont TH
J Cutan Pathol; 2010 Apr; 37(4):416-25. PubMed ID: 20377671
[TBL] [Abstract][Full Text] [Related]
30. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.
Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L
Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991
[TBL] [Abstract][Full Text] [Related]
31. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous immunofluorescence in dermatomyositis.
Nesbitt LT
Int J Dermatol; 1980 Jun; 19(5):270-8. PubMed ID: 6993383
[TBL] [Abstract][Full Text] [Related]
33. Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.
Kim JS; Werth VP
J Histochem Cytochem; 2011 Aug; 59(8):780-90. PubMed ID: 21804080
[TBL] [Abstract][Full Text] [Related]
34. The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus.
Cardinali C; Caproni M; Fabbri P
Clin Exp Rheumatol; 1999; 17(4):427-32. PubMed ID: 10464552
[TBL] [Abstract][Full Text] [Related]
35. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 expression in the skin of patients with lupus erythematosus.
Nürnberg W; Haas N; Schadendorf D; Czarnetzki BM
Exp Dermatol; 1995 Feb; 4(1):52-7. PubMed ID: 7757333
[TBL] [Abstract][Full Text] [Related]
37. C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases.
Braczynski AK; Harter PN; Zeiner PS; Drott U; Tews DS; Preusse C; Penski C; Dunst M; Weis J; Stenzel W; Mittelbronn M
Neuromuscul Disord; 2016; 26(4-5):283-91. PubMed ID: 27020463
[TBL] [Abstract][Full Text] [Related]
38. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells.
Janssens AS; Lashley EE; Out-Luiting CJ; Willemze R; Pavel S; de Gruijl FR
Exp Dermatol; 2005 Feb; 14(2):138-42. PubMed ID: 15679584
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
40. Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin.
French LE; Polla LL; Tschopp J; Schifferli JA
J Invest Dermatol; 1992 May; 98(5):758-63. PubMed ID: 1569324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
